Seradyn Innovations
Seradyn News Archive
Time Period: Category:
October 18, 2007 Thermo Fisher Scientific launches new assays to aid in the management of epilepsy Thermo Scientific QMS Lamotrigine and Thermo Scientific QMS Topiramate are now available for sale
October 1, 2007 Thermo Scientific Seradyn Sera-Mag® SpeedBeads™ NeutrAvidin magnetic particles now available Thermo Fisher Scientific Inc. (formerly Seradyn, Inc.) adds another magnetic particle product to its diverse portfolio.
June 25, 2007 Thermo Fisher Scientific Receives FDA Clearance for Thermo Scientific QMS® Lamotrigine Immunoassay The 510(k)clearance received by the FDA for the Thermo Scientific QMS® Lamotrigine Immunoassay further enhances Thermo Fisher Scientific's (formerly known as Seradyn, Inc.) position as a leader in the field of therapeutic drug management (TDM). The QMS Lamotrigine Immunoassay will soon be available for sale.
August 1, 2006 SpeedBead Magnetic Particles Seradyn announces the availability of its
Sera-Mag® SpeedBeads™ Magnetic particles. The Sera-Mag SpeedBeads are the newest entry in Seradyn’s Sera-Mag line of magnetic beads. These beads respond twice as fast to a magnetic field as our original Sera-Mag particles, and are available in carboxylate-modified and streptavidin coated versions.
August 1, 2006 QMS® Vancomycin Immunoassay Launched Seradyn, Inc is pleased to announce the launch of the QMS® Vancomycin immunoassay for the measurement of vancomycin levels in human serum and plasma.
February 17, 2006 Seradyn announces the availability of its QMS® Zonisamide Immunoassay for optimal epileptic patient care management Indianapolis, Indiana, Seradyn, Inc. announced today that it has launched the first immunoassay for Zonisamide for the quantitative determination of zonisamide levels in human serum or plasma.
February 1, 2006 New Microparticle-bound Protein Assay Seradyn announces the release of its revised Microparticle-bound Protein Assay protocol for measuring surface bound protein on Sera-Mag magnetic particles.
August 1, 2005 Innofluor Certican extraction volume reduction Seradyn announced a revised procedure that allows for Innofluor Certican extraction volume reduction and running samples and controls in singlet.
May 13, 2005 Int'l Congress of Therapeutic Drug Monitoring Seradyn presented a total of 11 posters at the 9th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology in Louisville, KY.
March 1, 2004 Clearance for Hemoglobin A1c (Hba1c) Test Abbott and Seradyn Announce U.S. Clearance for Hemoglobin A1c (Hba1c) Test for Diabetes.


^ Top | Previous Page | E-mail This Page